Bismee, N.N.; Javadi, N.; Khedr, A.; Omar, F.; Awad, K.; Abbas, M.T.; Scalia, I.G.; Pereyra, M.; Bcharah, G.; Farina, J.M.;
et al. Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management. J. Cardiovasc. Dev. Dis. 2024, 11, 384.
https://doi.org/10.3390/jcdd11120384
AMA Style
Bismee NN, Javadi N, Khedr A, Omar F, Awad K, Abbas MT, Scalia IG, Pereyra M, Bcharah G, Farina JM,
et al. Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management. Journal of Cardiovascular Development and Disease. 2024; 11(12):384.
https://doi.org/10.3390/jcdd11120384
Chicago/Turabian Style
Bismee, Nadera N., Niloofar Javadi, Ahmed Khedr, Fatma Omar, Kamal Awad, Mohammed Tiseer Abbas, Isabel G. Scalia, Milagros Pereyra, George Bcharah, Juan M. Farina,
and et al. 2024. "Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management" Journal of Cardiovascular Development and Disease 11, no. 12: 384.
https://doi.org/10.3390/jcdd11120384
APA Style
Bismee, N. N., Javadi, N., Khedr, A., Omar, F., Awad, K., Abbas, M. T., Scalia, I. G., Pereyra, M., Bcharah, G., Farina, J. M., Ayoub, C., Sell-Dottin, K. A., & Arsanjani, R.
(2024). Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management. Journal of Cardiovascular Development and Disease, 11(12), 384.
https://doi.org/10.3390/jcdd11120384